IL2-induced myocarditis, a relatively common reason for discontinuing IL-2 therapy, is clinically evident in up to approximately 25% of patients [4,7,11,12], however autopsy data suggest it may occur more frequently and can lead onto chronic myocardial fibrosis [13,14]. This evidence concerns the gene IL2 and myocarditis.